Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Amphenol (APH) delivered strong Q2 results and provided an upbeat Q3 outlook, which were both well received by investors. Revenue growth is...
— Silas Myers, Brian Massey
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Amphenol Corporation
We continued building our position in Amphenol Corporation during the third quarter after initiating it earlier in 2026. As a reminder,...
Amphenol Corporation ($APH) manufactures specialized electrical connectors, fiber-optic systems, and coaxial cables utilized across industrial, aerospace, and data infrastructure applications. The fund initiated...
Amphenol Corporation (APH) delivered a strong first quarter, reporting a book-to-bill ratio of 1.24x, driven by a 78% year-over-year increase in orders.
More institutional theses from Mar Vista US Quality
Stryker is a leading medical technology company offering specialized orthopedic implants, surgical equipment, and neurotechnology solutions to healthcare providers. The manager maintains...
Microsoft is a global enterprise technology platform providing productivity software, cloud computing infrastructure, and artificial intelligence solutions. Mar Vista maintains...
Apple designs premium consumer hardware devices, develops integrated operating systems, and delivers digital services across global markets. The manager maintains...